Teacher
Catarina Nascimento

Resume

I am a physician, veterinarian, and researcher with an interdisciplinary background in comparative medicine. I hold a Doctor of Veterinary Medicine (DVM), a PhD in Veterinary Sciences, and a Doctor of Medicine (MD). My research has primarily focused on comparative oncology, particularly feline mammary tumors, with interests in cancer biology, the tumor microenvironment, prognostic biomarkers, and translational medicine.

Graus

• Integrated Master's Degree
  Medicina Veterinária
• Doctorate
  Ciências Veterinárias
• Integrated Master's Degree
  Medicina

Publicações

Journal article

• 2023-01-06, TIM-3 Is a Potential Immune Checkpoint Target in Cats with Mammary Carcinoma, Cancers
• 2022-08-18, The Landscape of Tumor-Infiltrating Immune Cells in Feline Mammary Carcinoma: Pathological and Clinical Implications, Cells
• 2021-11-05, VISTA Is a Diagnostic Biomarker and Immunotherapy Target of Aggressive Feline Mammary Carcinoma Subtypes, Cancers
• 2021-05, Anaplastic Mammary Carcinoma in Cat, Veterinary Sciences
• 2021-04, HER2-Targeted Immunotherapy and Combined Protocols Showed Promising Antiproliferative Effects in Feline Mammary Carcinoma Cell-Based Models, Cancers
• 2021-03, Tyrosine Kinase Inhibitors Are Promising Therapeutic Tools for Cats with HER2-Positive Mammary Carcinoma, Pharmaceutics
• 2021-02-10, Serum and Tissue Expression Levels of Leptin and Leptin Receptor Are Putative Markers of Specific Feline Mammary Carcinoma Subtypes, Frontiers in Veterinary Science
• 2021-01, Diagnostic Value of VEGF-A, VEGFR-1 and VEGFR-2 in Feline Mammary Carcinoma, Cancers
• 2021, Tumor microenvironment of human breast cancer, and feline mammary carcinoma as a potential study model, Biochimica et Biophysica Acta - Reviews on Cancer
• 2020-05-28, Serum PD-1/PD-L1 Levels, Tumor Expression and PD-L1 Somatic Mutations in HER2-Positive and Triple Negative Normal-Like Feline Mammary Carcinoma Subtypes, Cancers
• 2020-03-02, Clinical Relevance of the serum CTLA-4 in Cats with Mammary Carcinoma, Scientific Reports

Conference abstract

• 2020-04-27, PD-1 and PD-L1 are diagnostic biomarkers and PD-L1 a promising therapeutic target in HER2-positive and triple negative normal-like feline mammary carcinoma subtypes